3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase EARLY_PHASE1
1
Phase 3
1
Phase 1/2
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Conditions
Carcinoma, Non-Small-Cell Lung
19
Lung Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Ovarian Neoplasms
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Squamous-Cell Lung Cancer
1
Small Cell Lung Carcinoma
1
Retinoblastoma
1
Retinal Neoplasms
1
Resectable Lung Non-Small Cell Carcinoma
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Cancer Recurrent
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
NSCLC
1
Head and Neck Neoplasms
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Carcinoma, Bronchogenic
1
Bronchial Neoplasms
1
Advanced Non Small Cell Lung Cancer
1
Adenocarcinoma of Lung
1
Interventions
Paclitaxel
134
Carboplatin
129
Bevacizumab
86
Gemcitabine
45
pembrolizumab
37
olaparib
33
Cisplatin
30
liposomal doxorubicin
29
Docetaxel
29
Cyclophosphamide
29
Topotecan
28
niraparib
27
Taxes
20
Etoposide
18
Filgrastim
16
Doxorubicin
16
Immunoglobulin G
15
Disulfides
15
apatinib
12
Letrozole
12
Albumin-Bound Paclitaxel
12
Drug Therapy
11
fluzoparib
10
fludarabine
10
Specimen Handling
10
Magnetic Resonance Spectroscopy
10
Biopsy
10
durvalumab
9
Nivolumab
9
pazopanib
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Ovarian Neoplasms
×
Platinum Compounds
×
Clear all
NCT07340164
2026-04-20
TROY
Yonsei University
Phase 2
Recruiting
116 enrolled
NCT02489006
2024-01-17
NEO
University Health Network, Toronto
Phase 2
Unknown
71 enrolled